CN107118247B - The preparation method of selamectin - Google Patents
The preparation method of selamectin Download PDFInfo
- Publication number
- CN107118247B CN107118247B CN201710444849.1A CN201710444849A CN107118247B CN 107118247 B CN107118247 B CN 107118247B CN 201710444849 A CN201710444849 A CN 201710444849A CN 107118247 B CN107118247 B CN 107118247B
- Authority
- CN
- China
- Prior art keywords
- obtains
- added
- acetone
- toluene
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Abstract
The present invention provides a kind of improved selamectin preparation process, the techniques are as follows: (1) doractin DL is in the presence of Wilson catalyst, hydrogen reducing, obtains intermediate SL1；(2) the intermediate SL1 that step (1) obtains passes through organic solvent hydrochloric acid solution (hydrogen chloride gas is dissolved in organic solvent) desugar, obtains intermediate SL2；(3) the intermediate SL2 that step (2) obtains passes through manganese dioxide, obtains intermediate SL3；(4) the intermediate SL3 that step (3) obtains passes through the oximate of hydroxylamine hydrochloride, obtains selamectin SL；(5) the crude product SL that step (4) obtains is recrystallized three times by toluene, acetone, methanol, obtains SL after purification.
Description
Technical field
The invention belongs to field of medicine production, are related to the preparation method of selamectin, in particular to high-purity selamectin
Preparation method.
Background technique
Avermectins medicine is the one group of Macrocyclolactone lactone kind medicine generated by streptomycete fermentation, can effectively prevent agriculture
Industry pest and a variety of harmful mites, the especially harmful mite to common pesticides with drug resistance and pest have excellent control efficiency.It is right
Crop is comparatively safe, and will not kill natural enemy, is conducive to the ecological balance.Meanwhile Avermectins medicine posts humans and animals
Raw nematode and arthropod class helminth have many advantages, such as to kill effect by force, and with wide spectrum, efficient and less toxic, animal with
And it is very extensive in terms of the control and application of human parasite.In the latest 20 years, using natural avermectin component as parent
It closes object progress structural modification transformation and achieves good progress, ivermectin (Ivermectin), doractin
(Doramectin), moxidectin (Moxidectin), eprinomectin (Eprinomectin) and selamectin
(Selamectin) be successful example, their anthelmintic activity and pharmacokinetic properties compared with parent compound have into
The raising and improvement of one step.
Selamectin (also referred to as hila rhzomorph) by genetic recombination Avid kyowamycin (Streptanyces avem
Itilis) new strains ferment, and are developed by Pfizer pharmacy, and to doractin progress chemical synthesis structural modification
It obtains, in July, 1999 lists in Britain for the first time, trade name Revolution.Its safety improves a lot, and takes orally, injection
There is good result, is a kind of inside and outside insecticide mainly for the adult flea of pet cat and dog, filaria and scabies.Its chemical name
(1- first propyl) -5- deoxidation -22,23- dihydro -5- (oximido)-AVERMECTIN B1 monosaccharide, molecular weight are removed for 25- cyclohexyl -25-
It is 769.96, for white or light yellow crystalline powder.
Chinese patent 94101917.9 is the compound patent of the selamectin of Pfizer Inc's application, the patent
Disclose the structural formula and preparation method of selamectin.It should be the preparation method comprises the following steps: being starting material, first step hydrogenation by doractin
Reaction uses Wilkinson catalyst, and toluene makees solvent preparation formula (II) compound, and second step desugar reaction is using sulfuric acid different
It is carried out in propyl alcohol.Third step oxidation reaction is carried out in anhydrous ether in the presence of activated manganese dioxide.4th step oximation reaction
It is completed in anhydrous pyridine using hydroxylamine hydrochloride.Most get Sai La bacterium is purified through silica gel chromatography and high pressure liquid chromatography afterwards
Element.On the whole, whole route prepares selamectin through over hydrogenation, desugar, oxidation, oximate and silica gel column purification.This technique is
The basic patent process route of selamectin, it is domestic more multi-vendor using the route, but the process overall yields are not high, and each
Intermediate requires silica gel chromatograph separation, and the selamectin crude product finally obtained is also needed by silica gel chromatography and high pressure
Liquid chromatography purification, entire technique are highly detrimental to industrialized production.
Chinese patent 98808106.7 is that follow-on selamectin preparation method of Pfizer Inc's application is special
Benefit, whole route have passed through hydrogenation, oxidation, desugar, oximate, and wherein desugar and oximate are that a step is completed, although the route phase
To shorter, but the toluene or methanol that the purifying of gained final product selamectin uses, both solvents do not have certain several impurity
Removal effect, resulting purification selamectin purity are still not high enough.And whole route yield is relatively low, only about 30%
~35%.
Chinese patent 201210102405.7 discloses the new technique for synthesizing of selamectin, as follows:
But it is lower by the selamectin crude product purity that the technique obtains, from 65.2%-81.2% etc., final step
The reverse phase C18 silica gel preparation higher selamectin of purity is still needed to, it is unfavorable to use industrialized production.
Veterinary drug registration technology requires report in international coordination meeting (VICH) GL 10, identifies and define limit and be respectively
0.10%, the 0.20% and 0.50% multiple unknown impurities of selamectin according to obtained by existing patent level at present are more than identification limit
(0.20%), and we when comparing the former triturate of Pfizer, find these it is more difficult purify in the impurity that goes there are two types of or
Two or more is not known impurities, therefore in imitative medicine process exploitation, and the selamectin that high-purity high-yield how is made will
Seem particularly critical.
Summary of the invention
The present invention provides a kind of improved selamectin preparation process, the route of the technique is as follows:
The present invention the specific process is as follows:
(1) doractin DL is in the presence of Wilson catalyst, hydrogen reducing, obtains intermediate SL1；
(2) the intermediate SL1 that step (1) obtains passes through organic solvent hydrochloric acid solution (hydrogen chloride gas is dissolved in organic solvent)
Desugar obtains intermediate SL2；
(3) the intermediate SL2 that step (2) obtains passes through manganese dioxide, obtains intermediate SL3；
(4) the intermediate SL3 that step (3) obtains passes through the oximate of hydroxylamine hydrochloride, obtains selamectin SL；
(5) the crude product SL that step (4) obtains is recrystallized three times by toluene, acetone, methanol, obtains SL after purification.
Wherein, in step (2), organic solvent hydrochloric acid solution can be dissolved in methanol, ethyl alcohol, isopropanol, fourth for hydrogen chloride gas
The solution of any mixed solvent of the alcohols solvents such as alcohol, methylene chloride, tetrahydrofuran, t-butyl methyl ether etc. or above-mentioned solvent, it is excellent
Isopropoxide acid solution is selected,
The mass fraction of organic solvent hydrochloric acid solution preferred 2.4%-4.8%, more preferable 3.6%.
Wherein, in step (5), the weight ratio of SL and toluene is 1:2~1:3, preferably 1:2.5；In step (5), by first
The SL of benzene crystallization and the weight ratio of acetone are 1:1~1:3, preferably 1:2.5；In step (5), the SL and methanol that are crystallized by acetone
Weight ratio be 1:1~1:3, preferably 1:2.5.
Preferably, technique of the invention is as follows:
(1) doractin DL is in the presence of Wilson catalyst, hydrogen reducing, obtains intermediate SL1；
(2) the intermediate SL1 that step (1) obtains passes through 3.6% isopropoxide acid solution desugar, obtains intermediate SL2；
(3) the intermediate SL2 that step (2) obtains passes through manganese dioxide, obtains intermediate SL3；
(4) the intermediate SL3 that step (3) obtains passes through the oximate of hydroxylamine hydrochloride, obtains selamectin SL；
(5) the crude product SL that step (4) obtains is recrystallized three times by toluene, acetone, methanol, obtains SL after purification,
The weight ratio of middle SL and toluene is 1:2.5, and the weight ratio of SL and acetone by toluene crystallization are 1:2.5, is crystallized by acetone
SL and methanol weight ratio be 1:2.5.
More specifically, the desugar reaction temperature of step (2) is 20-30 DEG C, preferably 22-24 DEG C.
More specifically, the crystallization purifications of step (5) are as follows: toluene is added in the crude product SL that step (4) obtains, is warming up to
45-50 DEG C, dissolution, natural cooling is cooled to room temperature, then is cooled to 0-5 DEG C, stirs, and filters, drying.
Acetone is added, is warming up to 40-45 DEG C, the product of previous step is added, all after dissolution, solid, heat preservation is precipitated in solid
40-45 DEG C of stirring, natural cooling are cooled to 10-15 DEG C of stirring, filter, and acetone elution filters, drying.
Methanol is added, is warming up to 40-45 DEG C, is added the product of previous step, after product dissolved clarification, solid is precipitated, keeps the temperature 40-45
DEG C stirring, natural cooling are cooled to 10-15 DEG C, filter, and methanol elution filters, drying.
Grope to test by early period, invention technician's discovery:
(1) after SL1 sulfuric acid desugar, SL toluene, recrystallizing methanol, ineffective, purity only has 92%, even if
It is crystallized again using methanol, toluene, purity also only promotes 1.4%, total miscellaneous > 6.5%, the miscellaneous > 0.2% of 8 lists, and yield
But 38% is dropped to from 49.1%.
(2) after SL1 sulfuric acid desugar, SL toluene, acetone, recrystallizing methanol, yield 96.8%, in order to further
Purity is improved, is crystallized again using acetone, although purity can reach 99.5%, but yield declines to a great extent to 32%.
(3) using 98808106.7 route and method prepare selamectin, total recovery 31.5%, purity 92.5%,
Yield and purity is not high, even if invention technician is crystallized again using methanol-toluene system, purity 93.5%, and yield
Drop to 21.6%.
Compared with prior art, the present invention main technical contribution is that SL1 uses the desugar of isopropoxide acid solution, SL warp
Cross toluene, acetone, methanol to crystallize three times, brought beneficial effect is: the purity of obtained selamectin finished product is very
Height is greater than 99.4%, and the miscellaneous content of all lists is respectively less than 0.2%, and while guaranteeing very high-purity, yield can reach
59.5%.
Detailed description of the invention
Fig. 1: the final sterling HPLC figure of the selamectin that embodiment 5 obtains.
Fig. 2: the final sterling HPLC figure of the selamectin that embodiment 6 obtains.
Fig. 3: the final sterling HPLC figure of the selamectin that embodiment 7 obtains.
Fig. 4: the final sterling HPLC figure of the selamectin that embodiment 8 obtains.
Specific embodiment
Summary of the invention is made further explanation and description below with reference to specific embodiment, still, they are not constituted
Limitation of the scope of the invention or restriction.
The preparation of 1 SL1 crude product of embodiment
20kg DL is added in 300L hydriding reactor, and 92kg acetone vacuumizes N2 and replaces 3 times, stops stirring, and Wilkinson is added and urges
Agent 200g, N2 displacement 3 times, H2 is replaced 3 times.Stirring is opened, 35-40 DEG C, Hydrogen Vapor Pressure 0.3-0.4Mpa, is reacted 3-4 hours,
HPLC monitoring, DL raw material peak area < 1.0% stop reaction, N2 displacement.40-50 DEG C of water pump reduced pressure of outer bath is evaporated to obtain
Crude product 21kg, purity 89.3%.
The preparation of 2 SL2 of embodiment
21kgSL1 and 200kg isopropanol is added in 500L stainless steel cauldron, stirs lower cloudy state, and temperature is 20.2 DEG C of
Isopropoxide acid solution 50kg (saliferous acid gas 1.8kg) is slowly added dropwise, being about added dropwise 20 minutes terminates, and nitrogen is protected after nitrogen vacuum breaker
Shield is lower to keep the temperature 22-24 DEG C of stir about 0.5h, and system dissolved clarification stirs HPLC monitoring in 2 hours, and SL1 < 6% stops reaction, will react
Liquid pours into 500kg ice water, and the extraction of 250kg methylene chloride is added, and water layer uses 120kg methylene chloride to extract again, merges organic layer,
Washed once with 5% sodium bicarbonate, then every time with 5% brine It three times.The dry 1h of organic addition 20kg anhydrous sodium sulfate,
Solid 30kg eluent methylene chloride is filtered, concentration dryed product is 20.5kg, purity 83.5%.
The preparation of 3 SL3 of embodiment
N2Protection, the 20.5kg SL2 crude product that 250kg methylene chloride is added in 500L stainless steel cauldron, embodiment 2 obtains
It is added with stirring 40kg electrolytic manganese dioxide, plus, nitrogen protection room temperature (20-25 DEG C) is stirred after manganese dioxide is soaked with methylene chloride
It mixes 1.5-2.5 hours, HPLC monitoring, SL2 < 1.0% stops reaction, pads diatomite, filters, eluent methylene chloride filter cake, merges
Filtrate, 45-50 DEG C of water pump concentration of outer bath is dry to obtain crude product 21.5kg, purity 84%.
The preparation of 4 SL crude product of embodiment
N2SL3 21.5kg and the 200kg isopropanol that embodiment 3 obtains, stirring and dissolving is added in protection, 500L stainless steel kettle.
10-15 DEG C of heat preservation, vacuum are pumped into the solution that 10.5kg hydroxylamine hydrochloride is dissolved in 30kg distilled water, used time 1-2 hour, finish nitrogen
Nitrogen protection after vacuum breaker, 25-30 DEG C of heat preservation are stirred to react 3-5 hours, and HPLC monitoring, SL3 < 1.0% stops reaction, will be anti-
It answers liquid to be pumped into 500kg ice water, the extraction of 250kg methylene chloride is added, water layer uses 125kg methylene chloride to extract again, merges organic
Layer, washed once, then primary with 100kg5% brine It with 100kg5% sodium bicarbonate.Outer 45-50 DEG C of bath is dense with water pump
Contract dry crude product 22kg, purity 85%.
The purification of 5 SL of embodiment
55kg toluene is added into the 22kg crude product that embodiment 5 obtains, is warming up to 45-50 DEG C, dissolution, natural cooling cools down
To room temperature (25-30 DEG C), then it is cooled to 0-5 DEG C of stirring 12-15 hours, filters wet product 45.8kg, sampling drying quantifies 23kg, very
40-43 DEG C of baking 12h discharging 13.8kg of empty baking oven water-bath, purity 96%.
40kg acetone is added in 100L stainless steel kettle, is warming up to 40-45 DEG C, is added at one time SL crude product (toluene crystallization)
Solid is precipitated in 16kg, solid quickly after all dissolving, keep the temperature 40-45 DEG C stirring 5-6 hours, natural cooling is cooled to 10-15 DEG C
Stirring 5h is filtered, and is eluted with 2L cold acetone, and wet product 18kg is filtered, and workshop vacuum drying oven room temperature draws 12h discharging 11.6kg.Purity
98.8%.
34kg methanol is added in 100L stainless steel kettle, is warming up to 40-45 DEG C, it is molten quickly to be added at one time the above 13.6kg product
Solid is slowly precipitated after honest and upright and thrifty 30 minutes, keeps the temperature 40-45 DEG C stirring 5-6 hours, natural cooling is cooled to 10-15 DEG C, filters, few
Cold methanol elution is measured, wet product 17.6kg is filtered, dries 10.2kg.Purity 99.4%.
The total recovery of embodiment 1 to embodiment 5 is 59.5%, and finished product purity is greater than 99.4%.
Analyze the final sterling of selamectin that embodiment 5 obtains: selamectin purity is 99.446%, total miscellaneous <
0.6%, all miscellaneous equal < 0.2% of list.
Embodiment 6
SL1 preparation:
40g DL is added in 500mL hydriding reactor, and 184g acetone vacuumizes N2Displacement 3 times, stops stirring, and Wilkinson is added and urges
Agent, N2Displacement 3 times, H2Displacement 3 times.Stirring is opened, 35-40 DEG C, Hydrogen Vapor Pressure 0.3-0.4Mpa, is reacted 3-4 hours, HPLC prison
Control, DL raw material peak area < 1.0% stop reaction, N2Displacement.40-50 DEG C of water pump reduced pressure of outer bath is evaporated to obtain crude product 40g,
Purity 88.5%.
SL2 preparation:
40g crude product SL1 and 320g isopropanol obtained in the previous step is added in 1000mL reaction flask, stirs lower cloudy state, temperature
Degree is that the 13.1g concentrated sulfuric acid is slowly added dropwise in 20.2 DEG C of, and being about added dropwise 20 minutes terminates, and 22-24 DEG C of stir about is kept the temperature under nitrogen protection
0.5h system dissolved clarification stirs HPLC monitoring in 2 hours, and SL1 < 6% stops reaction, reaction solution is poured into 1000g ice water, is added
The extraction of 500g methylene chloride, water layer use 250g methylene chloride to extract again, merge organic layer, washed once with 5% sodium bicarbonate, then
With 5% brine It.The dry 1h of organic addition 35g anhydrous sodium sulfate, filters mother liquor concentrations and does 41g, purity 78.2%.
SL3 preparation:
N2Protection, 570g methylene chloride is added in 1000mL stainless steel cauldron, 41g SL2 crude product obtained in the previous step stirs
Lower addition 72g electrolytic manganese dioxide is mixed, plus, (20-25 DEG C) of nitrogen protection room temperature is stirred after manganese dioxide is soaked with methylene chloride
1.5-2.5 hours, HPLC monitoring, SL2 < 1.0% stopped reaction, pads diatomite, filters, eluent methylene chloride filter cake, merged filter
Liquid, 45-50 DEG C of water pump concentration of outer bath is dry to obtain product 42g, purity 79%.
The preparation of SL crude product:
N2The dry 42gSL3 and 330g isopropanol of step concentration, stirring and dissolving is added in protection, 1000mL stainless steel kettle.Heat preservation
10-15 DEG C, vacuum is pumped into the solution that 21.5g hydroxylamine hydrochloride is dissolved in 60g distilled water, used time 1-2 hour, nitrogen protection, heat preservation
25-30 DEG C is stirred to react 3-5 hours, and HPLC monitoring, SL3 < 1.0% stops reaction, and reaction solution is pumped into 1000g ice water, is added
Enter the extraction of 500g methylene chloride, water layer uses 250g methylene chloride to extract again, merges organic layer, is washed with 200g5% sodium bicarbonate
Once, then it is primary with 200g5% brine It.45-50 DEG C of outer bath is concentrated dry crude product 42.5g with water pump.Purity 77.2%.
The crystallization of SL crude product methylbenzene methanol:
60g toluene is added in the 21.5g crude product done to above-mentioned concentration, is warming up to 45-50 DEG C, dissolution, natural cooling cools down
To room temperature (25-30 DEG C), then it is cooled to 0-5 DEG C of stirring 12-15 hours, filters wet product 26g, 40-43 DEG C of vacuum drying oven water-bath baking
12h discharging 12g.Purity 88%.
20g methanol is added in 100mL vial, is warming up to 40-45 DEG C, is added at one time the product 12g of previous step, solid is complete
30 minutes precipitation solids are stirred after portion's dissolution, keep the temperature 40-45 DEG C stirring 5-6 hours, natural cooling is cooled to 10-15 DEG C of stirring 5h
It filters, is eluted with 20ml cold methanol, filter wet product 11g, vacuum drying oven room temperature draws 12h discharging 8.4g, purity 92%, total recovery
49.1%.
15g methanol is added in 50mL vial, is warming up to 40-45 DEG C, is added at one time the product 8.4g of previous step, keeps the temperature
40-45 DEG C stirring 5-6 hours, natural cooling is cooled to 10-15 DEG C of stirring 5h and filters, and is eluted with 20ml cold methanol, filters wet
Product 11g, vacuum drying oven room temperature draw 12h discharging 7.2g, purity 93%.
The product 7.2g that 20g toluene is added at one time previous step is added in 50mL vial, is warming up to 45-50 DEG C, stirs 6h
Natural cooling is cooled to room temperature (25-30 DEG C), then is cooled to 0-5 DEG C of stirring 12-15 hours, filters wet product 26g, vacuum drying oven water
40-43 DEG C of baking 12h discharging 6.5g of bath, total recovery 38%, purity 93.4%.
Analyze the final sterling of selamectin that embodiment 6 obtains: selamectin purity is 93.465%, total miscellaneous >
6.5%, the miscellaneous > 0.2% of 8 lists.
Embodiment 7
60g toluene is added in the 20gSL crude product that embodiment 6 is obtained, is warming up to 45-50 DEG C, dissolution, natural cooling cools down
To room temperature (25-30 DEG C), then it is cooled to 0-5 DEG C of stirring 12-15 hours, filters wet product 25g, 40-43 DEG C of vacuum drying oven water-bath baking
12h discharging 11.8g.Purity 87.7%.
20g acetone is added in 100mL vial, is warming up to 40-45 DEG C, is added at one time SL crude product (toluene crystallization) 11.8g,
Solid is precipitated in solid quickly after all dissolving, keep the temperature 40-45 DEG C stirring 5-6 hours, natural cooling is cooled to 10-15 DEG C of stirring 5h
It filters, is eluted with 20ml cold methanol, filter wet product 12g, vacuum drying oven room temperature draws 12h discharging 8g.Purity 92.4%
16g methanol is added in 50mL vial, is warming up to 40-45 DEG C, is added at one time SL crude product (acetone crystallization) 8g, solid
30 minutes precipitation solids all are stirred after dissolution, keep the temperature 40-45 DEG C stirring 5-6 hours, natural cooling is cooled to 10-15 DEG C of stirring 5h
It filters, is eluted with 15ml cold methanol, filter wet product 10g, vacuum drying oven room temperature draws 12h discharging 6.5g.Purity 96.8%.
10g acetone is added in 50mL vial, is warming up to 40-45 DEG C, is added at one time SL crude product (acetone crystallization) 6.5g, Gu
Solid is precipitated in body quickly after all dissolving, keep the temperature 40-45 DEG C stirring 5-6 hours, and natural cooling is cooled to 10-15 DEG C of stirring 5h and takes out
Filter is eluted with 20ml cold methanol, filters wet product 8g, and vacuum drying oven room temperature draws 12h discharging 5.5g, purity 99.5%, yield
32%.
Analyze the final sterling of selamectin that embodiment 7 obtains: selamectin purity is 99.518%, total miscellaneous <
0.5%, all miscellaneous equal < 0.2% of list.
Embodiment 8
According to the route and method of Chinese invention patent 98808106.7, selamectin is prepared.
SL1 preparation
300g DL is added in 3000mL hydriding reactor, stops stirring after 1500ml acetone stirring dissolved clarification, Wilkinson catalyst is added
5.7g, N2Displacement 3 times.Open stirring at room temperature, Hydrogen Vapor Pressure 0.3-0.4Mpa reacts 7-9 hours, HPLC monitoring, DL raw material peak
Area < 1.0% stops reaction, N2Displacement.40-50 DEG C of water pump reduced pressure is bathed outside filtering insoluble substance mother liquor is evaporated addition acetonitrile
Dry the product 240g of 50 DEG C of vacuum of washing, purity 88.3%.
SL preparation
Above-mentioned SL1 150g is added in 2000ml reaction flask, and the manganese dioxide of activation is added after acetone 1200ml stirring dissolved clarification
362.2g stirs 1-2h at room temperature, and HPLC monitoring pads suction filtered through kieselguhr after reaction, collects mother liquor after solid acetonide elution, will
Isopropanol is added when mother liquor is distilled to small system continues distillation to temperature and rise to 80 DEG C, distills or be added isopropanol by continuing
So that volume is reached 500ml and 5ml water be added, be naturally cooling to room temperature be precipitated solid and be stirred overnight suction filtration obtain 50 DEG C of product baking
Dry 106g purity 87%.
Above-mentioned SL2 90g is added in 2000ml reaction flask room temperature, and isopropanol 720ml, water 90ml are added with stirring hydroxylamine hydrochloride
28.02g, system are warming up to 40-45 DEG C of gradually dissolved clarification, and insulated and stirred 17h HPLC monitoring reaction terminates, and system is poured into cold
The extraction of 600ml methylene chloride is added in 750ml water, the back extraction of water layer 300ml methylene chloride is primary, organic phase sodium bicarbonate washing one
Secondary, sodium chloride washing is primary, and toluene is added when distilling to small size for organic phase until temperature rises to 110 DEG C, then passes through distillation
Or the mode of addition toluene makes volume 720ml, is down to the suction filtration that is stirred overnight at room temperature and obtains 50 DEG C of drying 52.3g purity of product
91%.
100g methanol is added in 500mL vial, is warming up to 40-45 DEG C, is added at one time SL crude product (toluene crystallization)
52.3g, solid stir 30 minutes precipitation solids after all dissolving, keep the temperature 40-45 DEG C stirring 5-6 hours, natural cooling is cooled to
10-15 DEG C of stirring 5h is filtered, and is eluted with 10ml cold methanol, and wet product 50g is filtered, and vacuum drying oven room temperature draws 12h discharging 43g.Always
31.5% purity 92.5% of yield, above data are coincide with 98808106.7.
Reuse the crystallization of methanol-toluene system
90g methanol is added in 500mL vial, is warming up to 40-45 DEG C, is added at one time SL crude product (methanol crystallization) 43g, protects
Warm 40-45 DEG C of stirring 5-6 hours, natural cooling was cooled to 10-15 DEG C of stirring 5h and filters, and was eluted with 10ml cold methanol, filtered
Wet product 44g, vacuum drying oven room temperature draw 12h discharging 36g.Purity 93.2%
The above-mentioned methanol crystallization crude product of 37g is added in 200mL vial, and 80g toluene is added, is warming up to 45-50 DEG C of stirring 6h, from
It so cools to room temperature (25-30 DEG C), then is cooled to 0-5 DEG C of stirring 12-15 hours, filter wet product 21g, vacuum drying oven water-bath
40-43 DEG C of baking 12h discharging 29.5g, total recovery 21.6%, purity 93.5%.
Analyze the final sterling of selamectin that embodiment 8 obtains: selamectin purity is 93.534%, total miscellaneous
> 6.4%, the miscellaneous > 0.2% of 9 lists.
Claims (7)
1. a kind of preparation process of selamectin:
(1) doractin DL is in the presence of Wilson catalyst, hydrogen reducing, obtains intermediate SL1；
(2) the intermediate SL1 that step (1) obtains passes through the desugar of isopropoxide acid solution, obtains intermediate SL2；
(3) the intermediate SL2 that step (2) obtains passes through manganese dioxide, obtains intermediate SL3；
(4) the intermediate SL3 that step (3) obtains passes through the oximate of hydroxylamine hydrochloride, obtains selamectin SL；
(5) the crude product SL that step (4) obtains is recrystallized three times by toluene, acetone, methanol, obtains SL after purification；
Wherein, the crystallization purifications of step (5) are as follows: toluene is added in the crude product SL that step (4) obtains, is warming up to 45-50
DEG C, dissolution, natural cooling is cooled to room temperature, then is cooled to 0-5 DEG C, stirs, and filters, drying；
Acetone is added, is warming up to 40-45 DEG C, the product of previous step is added, solid all after dissolution, is precipitated solid, keeps the temperature 40-45
DEG C stirring, natural cooling is cooled to 10-15 DEG C of stirring, filters, and acetone elution is filtered, dried；
Methanol is added, is warming up to 40-45 DEG C, is added the product of previous step, after product dissolved clarification, solid is precipitated, 40-45 DEG C of heat preservation is stirred
It mixes, natural cooling is cooled to 10-15 DEG C, filters, and methanol elution filters, drying；
In step (5), the weight ratio of SL and toluene is 1:2~1:3, and the weight ratio of SL and acetone by toluene crystallization are 1:1
The weight ratio of~1:3, SL and methanol by acetone crystallization are 1:1~1:3.
2. preparation process as described in claim 1, the mass fraction of isopropoxide acid solution is 2.4%-4.8%.
3. preparation process as claimed in claim 2, the mass fraction of isopropoxide acid solution is 3.6%.
4. preparation process as described in claim 1, the desugar reaction temperature of step (2) is 20-30 DEG C.
5. preparation process as claimed in claim 4, the desugar reaction temperature of step (2) is 22-24 DEG C.
6. the weight ratio of preparation process a method as claimed in any one of claims 1 to 5, SL and toluene is 1:2.5, by toluene crystallization
The weight ratio of SL and acetone is 1:2.5, and the weight ratio of SL and methanol by acetone crystallization are 1:2.5.
7. preparation process as described in claim 1, are as follows:
(1) doractin DL is in the presence of Wilson catalyst, hydrogen reducing, obtains intermediate SL1；
(2) the intermediate SL1 that step (1) obtains passes through 3.6% isopropoxide acid solution, and the desugar at 22-24 DEG C obtains centre
Body SL2；
(3) the intermediate SL2 that step (2) obtains passes through manganese dioxide, obtains intermediate SL3；
(4) the intermediate SL3 that step (3) obtains passes through the oximate of hydroxylamine hydrochloride, obtains selamectin SL；
(5) toluene being added in the crude product SL that step (4) obtains, is warming up to 45-50 DEG C, dissolution, natural cooling is cooled to room temperature, then
It is cooled to 0-5 DEG C, is stirred, is filtered, drying；
Acetone is added, is warming up to 40-45 DEG C, the product of previous step is added, solid all after dissolution, is precipitated solid, keeps the temperature 40-45
DEG C stirring, natural cooling is cooled to 10-15 DEG C of stirring, filters, and acetone elution is filtered, dried；
Methanol is added, is warming up to 40-45 DEG C, is added the product of previous step, after product dissolved clarification, solid is precipitated, 40-45 DEG C of heat preservation is stirred
It mixes, natural cooling is cooled to 10-15 DEG C, filters, and methanol elution filters, drying；
Wherein, the weight ratio of SL and toluene is 1:2.5, and the weight ratio of SL and acetone by toluene crystallization are 1:2.5, by third
The SL of ketone crystallization and the weight ratio of methanol are 1:2.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710444849.1A CN107118247B (en) | 2017-06-14 | 2017-06-14 | The preparation method of selamectin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710444849.1A CN107118247B (en) | 2017-06-14 | 2017-06-14 | The preparation method of selamectin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107118247A CN107118247A (en) | 2017-09-01 |
| CN107118247B true CN107118247B (en) | 2019-07-26 |
Family
ID=59730455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710444849.1A Active CN107118247B (en) | 2017-06-14 | 2017-06-14 | The preparation method of selamectin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107118247B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102020062B1 (en) * | 2017-11-17 | 2019-09-10 | 주식회사 종근당바이오 | New Selamectin Intermediates, Preparation Method Thereof And Preparation Method For Selamectin Using The Same |
| CN114106071A (en) * | 2021-11-11 | 2022-03-01 | 浙江荣耀生物科技股份有限公司 | Synthesis method of selamectin |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099394A (en) * | 1993-01-18 | 1995-03-01 | 美国辉瑞有限公司 | Antiparasitic agents |
| CN1141044A (en) * | 1994-02-16 | 1997-01-22 | 美国辉瑞有限公司 | Antiparasitic agents |
| CN1265113A (en) * | 1997-07-23 | 2000-08-30 | 美国辉瑞有限公司 | Prodn. method of avermectin compounds |
| CN1266437A (en) * | 1997-08-05 | 2000-09-13 | 美国辉瑞有限公司 | Improved process for antiparasitic agent |
| CN103360444A (en) * | 2012-04-03 | 2013-10-23 | 浙江海正药业股份有限公司 | Novel synthesis process of antiparasitic drug, namely selamectin |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9312154D0 (en) * | 1993-06-12 | 1993-07-28 | Pfizer Ltd | Antiparasitic agents |
-
2017
- 2017-06-14 CN CN201710444849.1A patent/CN107118247B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099394A (en) * | 1993-01-18 | 1995-03-01 | 美国辉瑞有限公司 | Antiparasitic agents |
| CN1141044A (en) * | 1994-02-16 | 1997-01-22 | 美国辉瑞有限公司 | Antiparasitic agents |
| CN1265113A (en) * | 1997-07-23 | 2000-08-30 | 美国辉瑞有限公司 | Prodn. method of avermectin compounds |
| CN1266437A (en) * | 1997-08-05 | 2000-09-13 | 美国辉瑞有限公司 | Improved process for antiparasitic agent |
| CN103360444A (en) * | 2012-04-03 | 2013-10-23 | 浙江海正药业股份有限公司 | Novel synthesis process of antiparasitic drug, namely selamectin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107118247A (en) | 2017-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107021990B (en) | The preparation method of high-purity selamectin | |
| CN103360444B (en) | The new technique for synthesizing of antiparasitic agent selamectin | |
| CN107118247B (en) | The preparation method of selamectin | |
| CN112679420B (en) | Preparation method of 2,5-dibromopyridine | |
| US20110195947A1 (en) | Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same | |
| CN108473524B (en) | Preparation method of tulathromycin and intermediate thereof | |
| CN101058598B (en) | Method of synthesizing 2alpha,3alpha-epoxy-16alpha-bromo-5alpha-androsterone-17-one | |
| CN102731523B (en) | Preparation method of beta-artemether | |
| CN102127024A (en) | Method for synthesizing 4-aryl-1H-1,2,3-triazole by using 1,1-dibromo-1-olefin | |
| CN108264454B (en) | Preparation method of phloroglucinol derivative and intermediate | |
| EP2985023A1 (en) | Process for preparing prasugrel | |
| WO2006011160A1 (en) | Process for the preparation of azithromycin monohydrate isopropanol clathrate | |
| CN105820202B (en) | A kind of avermectin derivatives and its preparation method and application | |
| CN103130708B (en) | A kind of preparation method of N-tertbutyloxycarbonyl-4-nitro piperidines | |
| CN113527236B (en) | Method for preparing amiodarone hydrochloride | |
| CN111825678A (en) | Preparation method of carbamatinib | |
| CN113999164B (en) | Preparation method of halofuginone intermediate trans-N-benzyloxycarbonyl- (3-hydroxy-2-piperidinyl) -2-propanone | |
| CN107641080B (en) | A kind of dihydronaphthalene ketones derivant and preparation method thereof containing spirane structure | |
| CN105175316B (en) | A kind of method for preparing laxative picosulfate sodium | |
| CN104829541A (en) | High selectivity and high purity method for preparing morinidazole | |
| CN108947953B (en) | Synthetic method of flavonoid derivative | |
| CN110669031B (en) | Total synthesis method of natural product isoperidone J | |
| CN112759570B (en) | Method for synthesizing simvastatin impurity D | |
| CN107176940B (en) | A kind of preparation method for block-regulations woods | |
| CN103435675B (en) | Method for refining steroid muscle relaxant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200312 Address after: 225400 No. 22 Binjiang South Road, Taixing Economic Development Zone, Taizhou City, Jiangsu Province Co-patentee after: BrightGene Bio-Medical Technology Co.,Ltd. Patentee after: Borui Biomedicine Taixing Co., Ltd. Address before: 215123 C25 Building, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu Province Patentee before: BrightGene Bio-Medical Technology Co.,Ltd. |